English
Mono Pharmacare Q2 Results
- BSE: -
- NSE: MONOPHARMA
- ISIN: INE0OIP01012
- Sector: Biotechnology & Drugs
BSE
This stock is not traded on BSE
NSE
11.90
-0.60 (-4.80%)
-0.60 (-4.80%)Volume10.00 K
Updated: Wed 21 Jan, 2026 | 15:09:57
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q2 Results Highlights
- Total Income₹66.29 Cr.(-23.95%)
- Operating Profit₹1.71 Cr.(-63.34%)
- Profit After Tax₹0.02 Cr.(-99.10%)
- Operating Margin2.58%(-54.99%)
Note: Comparison is on YoY basis
Quarterly - Mono Pharmacare Q2 Results
*All figures in crores except per share values
| Fiscal Period | Sep 25 | - | QoQ Comp | Sep 23 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 64.58 | - | N/A | 62.71 | -21.71% |
| Depreciation/ Amortization | 0.06 | - | N/A | 0.05 | -9.81% |
| Operating Income | 1.71 | - | N/A | 3.82 | -63.34% |
| Net Income | 0.02 | - | N/A | 1.88 | -99.10% |
| Other Operating Expenses Total | 0.69 | - | N/A | 0.55 | -49.61% |
| Net Income Before Taxes | 0.12 | - | N/A | 2.36 | -96.15% |
| Total Revenue | 66.29 | - | N/A | 66.53 | -23.95% |
| Selling/ General/ Admin Expenses Total | 2.04 | - | N/A | 1.81 | 20.08% |
| Diluted Normalized EPS | 0.01 | - | N/A | 1.43 | -99.23% |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.